Composition
- Active ingredients
- LAMIVUDINE 150MG; ZIDOVUDINE 300MG; NEVIRAPINE 200MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021971.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lamivudine; Zidovudine; Nevirapine
- Active substance
- lamivudine
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Cipla Limited
- Status
- Tentative approval
- FDA approval
- 31 Jan 2007
- Application
- NDA021971-001